EBElena V. Barsukova

Elena V. Barsukova

*This is an algorithmically generated author record based on publicly available information.

Elena V. Barsukova has a total of 28 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Toxic epidermal necrolysis (Lyell's syndrome) in a patient treated with amoxicillin with clavulanic acid

    by E. A. Solenova, E. V. Barsukova, E. V. Ivanova, A. N. Krytsova, T. V. Krasnova, P. I. Pavlov, S. M. Zhuchkova

    Toxic epidermal necrolysis (Lyell's syndrome) is a life-threatening toxic-allergic reaction with a high mortality rate. The relevance of the problem is due to the risk of developing this reaction to frequently prescribed antibacterial drugs in outpatient practice (in particular, inhibitor-protected penicillins), the complexity of diagnosis, as well as the lack of clinical guidelines approved by the Ministry of Health of the Russian Federation. The purpose of this study was to present a clinical case of toxic epidermal necrolysis associated with the use of amoxicillin+clavulanic acid and to draw attention to the issues of diagnosis and safety of antimicrobial therapy for community-acquired infections at the outpatient stage. Materials and methods . A 76-year-old patient with a history of hypertension, diabetes mellitus, and rectal cancer was prospectively observed for toxic epidermal necrolysis caused by amoxicillin+clavulanic acid, and his primary medical records. Research results . On the third day of taking amoxicillin+clavulanic acid for acute right-sided maxillary sinusitis, the patient developed toxic epidermal necrolysis with a high risk of mortality (≥ 90 % according to the SCORTEN scale). After discontinuation of the medication, hospitalization in a specialized department, and pathogenetic and symptomatic pharmacotherapy for the main and concomitant diseases, the patient showed a stable positive trend and complete regression of the skin lesions by the time of discharge from the hospital. Conclusions . The presented case confirms the need for a thorough collection of a pharmacological history and consultation with a clinical pharmacologist when patients present with any skin lesions associated with the use of medications. The approval of clinical guidelines for toxic epidermal necrolysis is a necessary measure for developing modern treatment and diagnostic strategies for managing patients with this adverse reaction, as well as for updating medical and economic standards for providing healthcare.

  • THE EFFECT OF COVID-19 ON MYOCARDIAL DAMAGE: A CLINICAL CASE

    by Nadezhda V. Zhuravleva, Vadim E. Babokin, Elena V. Barsukova, Luiza M. Karzakova, Rosa V. Fomina, Nadezhda A. Komelyagina, Tatyana L. Smirnova, Kseniya I. Platonova, Nadezhda D. Ukhterova, Tatyana S. Lutkova, et al.

    Despite the fact that the general clinical manifestations of COVID-19 are well known, there remain problems associated with the impact of COVID-19 on human health, in addition to its effects on the respiratory system. Patients with COVID-19 and concomitant cardiovascular diseases are more likely to be hospitalized and to pass treatment in the intensive care units and to have worse prognoses. The article discusses the problems arising from the effect of type 2 coronavirus acute respiratory syndrome (SARS-CoV-2) on the cardiovascular system, starting with the mechanisms associated with angiotensin converting enzyme 2 (ACE2) receptors, as well as discusses cases of major pathological changes in the heart and blood vessels that are detected in these patients. In addition to the known risk factors for severe COVID-19: cardiovascular diseases, diabetes mellitus, chronic lung diseases and old age, even young patients without a history of risk factors may develop myocardial damage. We present a description of a clinical case of acute myocardial infarction against the background of a new coronavirus infection COVID-19 in a patient aged 28 years with a diagnosis of coronary heart disease.


  • Open Access

    Map analysis of morbidity and mortality from blood circulatory system diseases of the population of the Russian federation (2010-2019)

    by O. V. Sharapova, D. I. Kicha, L. I. Gerasimova, O. V. Rukodaynyy, R. V. Fomina, A. V. Evzerikhina, E. V. Barsukova

    Highlights. For the first time, mapping models of morbidity and mortality from the blood circulation system diseases for assessing the performance of the health protection system in federal districts of the Russian Federation were proposed. The method makes it possible to identify low-quality health systems, and outsider regions, where it is necessary to develop measures in order to identify modifiable and non-modifiable risk factors and improve the performance of health care system both in federal districts and in the Russian Federation as a whole.Aim. To develop mapping models of morbidity and mortality from the blood circulation system diseases (BCSD) and to propose indices for assessing the performance of the health care system in different federal districts of Russia over a 10-year period (from 2010 to 2019).Methods. Reporting forms of federal statistical observation in the field of public health were used.Results. The incidence of BCSD among the population of the Russian Federation has been steadily increasing over the past two decades, increasing 2.047-fold from 2000 to 2019, while the mortality rate of the Russian population decreased 2.073-fold over the same period. Mapping models of morbidity and mortality from BCSD have been developed and indices for assessing the performance of the health protection system in different federal districts of Russia over a 10-year period (from 2010 to 2019) have been proposed.Conclusion. The mapping of low and ultra-low incidence rates of BCSD combined with high and ultra-high mortality rates from BSC among the population of the federal districts indicates low detection rates and low performance of the primary health care system in detecting BSC among the population assigned to receive primary health care according to the territorial principle. The correlation of indicators of general morbidity and mortality from HIPC in relation to health care resources allows timely assessment and finding resources in those areas that contribute to the maximum efficiency of medical organizations at minimum cost.


  • Open Access

    Change in concentration of ammonia and other biochemical indicators in patients with new coronaviral infection

    by L. B. Lazebnik, L. V. Tarasova, E. A. Komarova, Yu. V. Tsyganova, E. I. Busalaeva, E. V. Вarsukova, F. Oreshnikova, A. V. Oreshnikov

    The article demonstrates the results of a study to study the comparative assessment of the concentration of ammonia in the peripheral blood of patients with a viral infection of COVID-19 against the background of previously existing hepatic pathology and without it. There was a correlation between peripheral blood hyperammonemia and an increase in the concentration of markers of acute inflammation. The relationship between a high degree of hyperammonemia and a severe course / death as a result of the development of a new coronavirus infection in the studied patients was traced. The role of the initial chronic hepatic pathology (including non-alcoholic fatty liver disease) as a factor in the unfavorable course of the new coronavirus infection is highlighted.